XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenues
General and administrative costs:        
Compensation to related parties, including stock-based compensation expense of $130,691 and $280,060 for the three months ended June 30, 2024 and 2023, respectively, and $233,618 and $557,040 for the six months ended June 30, 2024 and 2023, respectively 306,354 522,561 624,016 1,042,041
Patent and licensing legal and filing fees and costs 63,612 340,010 146,823 657,350
Other costs and expenses 428,482 379,970 875,424 724,212
Research and development costs, including $67,119 and $53,178 for the three months ended June 30, 2024 and 2023, respectively, and $134,084 and $105,382 for the six months ended June 30, 2024 and 2023, respectively, to a related party 210,708 427,457 329,772 616,542
Total costs and expenses 1,009,156 1,669,998 1,976,035 3,040,145
Loss from operations (1,009,156) (1,669,998) (1,976,035) (3,040,145)
Interest income 2,233 2,714 5,092 7,729
Interest expense (4,154) (1,948) (11,340) (5,809)
Foreign currency gain 158 877 42 2,211
Net loss $ (1,010,919) $ (1,668,355) $ (1,982,241) $ (3,036,014)
Net loss per common share basic $ (0.45) $ (1.00) $ (0.88) $ (1.82)
Net loss per common share diluted $ (0.45) $ (1.00) $ (0.88) $ (1.82)
Weighted average common shares outstanding basic 2,249,290 1,665,956 2,249,290 1,665,479
Weighted average common shares outstanding diluted 2,249,290 1,665,956 2,249,290 1,665,479